Economic Feasibility of New Chemotherapy Regimens for Treatment of Tuberculosis Patients With Extensive Drug Resistance

Tuberkulëz i bolezni lëgkikh - Russian Federation
doi 10.21292/2075-1230-2018-96-6-7-14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

New Terra

Related search

A Clinical Case of Effective Treatment of Extensive Drug Resistance Tuberculosis With New Anti-Tuberculosis Drugs

Tuberkulëz i bolezni lëgkikh
PulmonaryInfectious DiseasesRespiratory Medicine
2017English

Efficiency of Valve Bronchial Block Within Comprehensive Treatment of Pulmonary Tuberculosis Patients With Extensive Drug Resistance

Tuberkulëz i bolezni lëgkikh
PulmonaryInfectious DiseasesRespiratory Medicine
2018English

Clinical and Economic Analysis of the Use of Valve Bronchial Block for Treatment of Patients Suffering From Destructive Pulmonary Tuberculosis With Extensive Drug Resistance

Tuberkulëz i bolezni lëgkikh
PulmonaryInfectious DiseasesRespiratory Medicine
2019English

Revolutionary New Treatment Regimens for Multidrug-Resistant Tuberculosis

The Lancet Infectious Diseases
Infectious Diseases
2019English

Drug Treatment of Tuberculosis: I. Standard Chemotherapy

BMJ
1960English

Treatment Outcomes of Regimens Containing Delamanid Within Therapy of Multiple and Extensive Drug Resistant Tuberculosis in the Russian Federation

Tuberkulëz i bolezni lëgkikh
PulmonaryInfectious DiseasesRespiratory Medicine
2019English

A Study of Drug Resistance TB Among Patients With New Sputum Smear Positive Pulmonary Tuberculosis

IOSR Journal of Dental and Medical Sciences
2016English

Final Treatment Outcomes of Multidrug- And Extensively Drug-Resistant Tuberculosis Patients in Latvia Receiving Delamanid-Containing Regimens

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2017English

Drug Resistance Pattern in Pulmonary Tuberculosis Patients and Risk Factors Associated With Multi-Drug Resistant Tuberculosis

Journal of Tuberculosis Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy